This protocol applies to children and adolescents — ages 12 years and older — presenting with mild to moderate plaque psoriasis. Topical therapy is the established first-line approach for this population and disease severity.
Management centres on topical therapy directed at involved skin. The protocol specifies which class or classes of topical agent are appropriate, including guidance on duration and patient age. The complete agent selection and any combination approach are contained in the full protocol.